CKD and Cerebral Microbleeds: Pathophysiologic Insights and Implications for Nephrology

Area of Science:

• Nephrology
• Neurology
• Vascular Biology

Background:

• Chronic kidney disease (CKD) is a growing global health issue.
• CKD is a known risk factor for vascular damage.
• Cerebral microbleeds (CMB), indicators of brain microvascular hemorrhage, are more common in CKD patients.

Purpose of the Study:

• To review and synthesize evidence on the relationship between CKD and CMB.
• To explore the mechanistic pathways linking CKD to CMB.
• To highlight the clinical implications of CKD-associated CMB.

Main Methods:

• Integration of data from epidemiological studies.
• Analysis of neuropathological findings.
• Review of experimental models investigating CKD-CMB links.

Main Results:

• CKD is independently associated with an increased prevalence of CMB.
• Key mechanisms include uremic toxin effects on endothelium, vascular calcification, and blood pressure variability.
• These factors compromise microvascular integrity, leading to CMB.

Conclusions:

• CKD is a significant, independent risk factor for CMB.
• CKD-related CMB represents a critical cerebrovascular complication.
• Strategies targeting vascular protection and uremic toxin reduction may improve brain health in CKD.